2CE

N-[2-(2-CARBAMOYLMETHOXY-ETHOXY)-ETHYL]-2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE

Created:	2005-07-04
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where 2CE is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	68
Chiral Atom Count	1
Bond Count	69
Aromatic Bond Count	12

2D diagram of 2CE

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[2-(2-CARBAMOYLMETHOXY-ETHOXY)-ETHYL]-2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE
Systematic Name (OpenEye OEToolkits)	(2S)-N-[2-[2-(2-amino-2-oxo-ethoxy)ethoxy]ethyl]-3-(4-carbamimidamidophenyl)-2-[2-(4-chlorophenyl)sulfanylethanoylamino]propanamide
Formula	C₂₄ H₃₁ Cl N₆ O₅ S
Molecular Weight	551.058
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	Clc2ccc(SCC(=O)NC(C(=O)NCCOCCOCC(=O)N)Cc1ccc(NC(=[N@H])N)cc1)cc2
SMILES	CACTVS	3.341	NC(=N)Nc1ccc(C[CH](NC(=O)CSc2ccc(Cl)cc2)C(=O)NCCOCCOCC(N)=O)cc1
SMILES	OpenEye OEToolkits	1.5.0	[H]N=C(N)Nc1ccc(cc1)CC(C(=O)NCCOCCOCC(=O)N)NC(=O)CSc2ccc(cc2)Cl
Canonical SMILES	CACTVS	3.341	NC(=N)Nc1ccc(C[C@H](NC(=O)CSc2ccc(Cl)cc2)C(=O)NCCOCCOCC(N)=O)cc1
Canonical SMILES	OpenEye OEToolkits	1.5.0	[H]/N=C(\N)/Nc1ccc(cc1)C[C@@H](C(=O)NCCOCCOCC(=O)N)NC(=O)CSc2ccc(cc2)Cl
InChI	InChI	1.03	InChI=1S/C24H31ClN6O5S/c25-17-3-7-19(8-4-17)37-15-22(33)31-20(13-16-1-5-18(6-2-16)30-24(27)28)23(34)29-9-10-35-11-12-36-14-21(26)32/h1-8,20H,9-15H2,(H2,26,32)(H,29,34)(H,31,33)(H4,27,28,30)/t20-/m0/s1
InChIKey	InChI	1.03	SUVIJSGBAJVXMV-FQEVSTJZSA-N

Related Resource References

Resource Name	Reference
PubChem	11957381

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.